Company / Current Assets
BIOCRYST PHARMACEUTICALS INC Current Assets History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Current Assets
$404.3M
FY2025
5-year range
$404.3M / $566.1M
FY2021-FY2025
Trend
-4.2%
vs FY2024
Sector context
#135 of 213
Health Care
What the data says
At $404M, BIOCRYST PHARMACEUTICALS INC's current assets ranks #135 of 213 in the Health Care sector. Current Assets has declined for 4 consecutive years, from $566M in FY2021 to $404M in FY2025.
Based on SEC 10-K filings.
$404M in FY2025 with a 5-year CAGR of +4.5%.
Declined from $496M to $404M over the past 2 years.
Health Care sector context is included.
Current Assets over time
Growth rates
- 3-Year CAGR
- -7.8%
- 5-Year CAGR
- +4.5%
- 10-Year CAGR
- -
Sector benchmark
#135 of 213 in Health CareTop 63% of 213This company $404.3M Sector average $2.5B
▼
-84.0% below sector average
Key checks
Key Insights
- BIOCRYST PHARMACEUTICALS INC's current assets has declined for 4 consecutive years.
- 5-year CAGR of +4.5%, indicating consistent growth.
- In FY2025, current assets decreased 4.2% year-over-year.
- Ranks #135 out of 213 companies in the Health Care sector.
Company context
Key Data Points
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Current AssetsValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $404.3M | -4.2% |
| FY2024 | $422.0M | -14.9% |
| FY2023 | $496.0M | -4.0% |
| FY2022 | $516.5M | -8.8% |
| FY2021 | $566.1M | +74.8% |
| FY2020 | $323.8M | +97.0% |
| FY2019 | $164.3M | +43.7% |
| FY2018 | $114.4M | -8.8% |
| FY2017 | $125.4M | +87.2% |
| FY2016 | $67.0M | +5.0% |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026